0000899243-20-014517.txt : 20200529
0000899243-20-014517.hdr.sgml : 20200529
20200529143240
ACCESSION NUMBER: 0000899243-20-014517
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200528
FILED AS OF DATE: 20200529
DATE AS OF CHANGE: 20200529
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Truitt Joseph
CENTRAL INDEX KEY: 0001452429
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19879
FILM NUMBER: 20926832
MAIL ADDRESS:
STREET 1: C/O ACHILLION PHARMACEUTICALS, INC.
STREET 2: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-28
0
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001452429
Truitt Joseph
C/O BIOSPECIFICS TECHNOLOGIES CORP.
2 RIGHTER PKWY, DELAWARE CORP. CENTER II
WILMINGTON
DE
19803
1
1
0
0
Chief Executive Officer
Stock Option (Right to Buy)
63.72
2020-05-28
4
A
0
130000
0.00
A
2030-05-28
Common Stock
130000
130000
D
The stock options were granted under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan.
The stock options vest in four equal installments over the four-year period following the date of grant.
/s/ Joseph E. Truitt by Carl A. Valenstein, attorney- in-fact
2020-05-29